Innovative Biodegradable Alloy Advances Bone Implants
|
By HospiMedica International staff writers Posted on 16 Jul 2020 |
|
Image: Dr. Alexander Komissarov testing the magnesium, gallium, and zinc alloy (Photo courtesy of NUST-MISiS)
A new bioresorbable alloy based on magnesium, gallium, and zinc can be used to make temporary implants for the treatment of fractures, osteoporosis, and myeloma.
Developed at the Russian National University of Science and Technology (NUST-MISiS; Moscow, Russia), Monash University (Melbourne, Australia), and other institutions, the new bioresorbable alloy takes advantage of the efficacy of gallium in inhibiting bone resorption, osteoporosis, Paget's disease, and other illnesses. The alloy is intended for use in the manufacture of temporary implants for the treatment of fractures, and the restoration of surgically removed bone due to pathologies.
A severe plastic deformation technique of equal channel angular pressing (ECAP) provides the alloy with favorable mechanical properties and a low rate of degradation and biocorrosion, in contrast to alloys that are based largely on magnesium. As result, it does not undergo a rapid decomposition process in the environment of the human body, and retains its supporting functions throughout the healing process. The study was published on May 12, 2020, in the Journal of Magnesium and Alloys.
“Gallium is known as an ‘inhibitor’ of bone resorption, it is effective in treating disorders associated with accelerated bone loss,” said Alexander Komissarov, PhD, head of the Hybrid Nanostructured Materials Laboratory at NUST MISIS. “Gallium is also involved in biochemical regeneration processes, increasing the thickness, strength, and mineral content of the bone. Finally, it has an antibacterial effect, which is especially important in implantology.”
Gallium is predominantly used in electronics. And although gallium it has no natural function in biology, gallium ions interact with processes in the body in a manner similar to iron (Fe). The body therefore handles Gallium as though it were Fe3+, and the ion is bound in areas of inflammation, such as infection, and in areas of rapid cell division. It is also used in nuclear medicine imaging radiopharmaceutical agents (Gallium scan), such as the radioactive isotope 67Ga.
Related Links:
Russian National University of Science and Technology
Monash University
Developed at the Russian National University of Science and Technology (NUST-MISiS; Moscow, Russia), Monash University (Melbourne, Australia), and other institutions, the new bioresorbable alloy takes advantage of the efficacy of gallium in inhibiting bone resorption, osteoporosis, Paget's disease, and other illnesses. The alloy is intended for use in the manufacture of temporary implants for the treatment of fractures, and the restoration of surgically removed bone due to pathologies.
A severe plastic deformation technique of equal channel angular pressing (ECAP) provides the alloy with favorable mechanical properties and a low rate of degradation and biocorrosion, in contrast to alloys that are based largely on magnesium. As result, it does not undergo a rapid decomposition process in the environment of the human body, and retains its supporting functions throughout the healing process. The study was published on May 12, 2020, in the Journal of Magnesium and Alloys.
“Gallium is known as an ‘inhibitor’ of bone resorption, it is effective in treating disorders associated with accelerated bone loss,” said Alexander Komissarov, PhD, head of the Hybrid Nanostructured Materials Laboratory at NUST MISIS. “Gallium is also involved in biochemical regeneration processes, increasing the thickness, strength, and mineral content of the bone. Finally, it has an antibacterial effect, which is especially important in implantology.”
Gallium is predominantly used in electronics. And although gallium it has no natural function in biology, gallium ions interact with processes in the body in a manner similar to iron (Fe). The body therefore handles Gallium as though it were Fe3+, and the ion is bound in areas of inflammation, such as infection, and in areas of rapid cell division. It is also used in nuclear medicine imaging radiopharmaceutical agents (Gallium scan), such as the radioactive isotope 67Ga.
Related Links:
Russian National University of Science and Technology
Monash University
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Tourniquet System
heidi– mein Tourniquet
New
Multi-Chamber Washer-Disinfector
WD 390
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
